IMMUNMODULATORISCHE MITTEL

European patent · EP3094351 · In force

Register entry

Publication number
EP3094351
Application number
EP15736953
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Corrected
Filed
Jan 15, 2015
Published
Nov 23, 2016
Granted
Dec 29, 2021
Protection ends at the latest
Jan 14, 2035
Next annual fee due
Jan 31, 2027
IPC classes
A61K 39/395 (2006.01)
C07K 16/28 (2006.01)
C07K 16/24 (2006.01)
C07K 16/46 (2006.01)
C07K 14/715 (2006.01)
C07K 14/54 (2006.01)
A61K 39/00 (2006.01)
A61K 47/68 (2017.01)
A61P 31/12 (2006.01)
A61P 35/00 (2006.01)
A61P 37/04 (2006.01)
Priority
US 201461927907 P 15.01.2014
PCT application
PCT/US2015/011657 15.01.2015
PCT publication
WO2015/109124 23.07.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Nov 9, 2022

    Change

    Published in Swissreg on 09.11.2022

  6. Mar 16, 2022

    Change

    Published in Swissreg on 16.03.2022

  7. Dec 29, 2021

    Granted

    Published in Swissreg on 29.12.2021

Parties

Holder

Kadmon Corporation, LLC

450 East 29th St., New York, NY 10016, US

Inventor

ZHONG, Zhaojing

Bronx, NY 10461, US

ZHU, Zhenping

New York, NY 10016, US

WU, Yan

Doylestown, PA 18902, US

MARTOMO, Stella, A.

Edgewater, NJ 07020, US

WAKSAL, Samuel, D.

New York, NY 10028, US

LU, Dan

Montvale, NJ 07645, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.